These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [HIV: to administer protease inhibitors early]. Dtsch Med Wochenschr; 1996 Dec; 121(49):A49. PubMed ID: 8998916 [No Abstract] [Full Text] [Related]
24. [Observational study on the efficacy of the application of two classical regimens of triple antiretroviral therapy]. Eiros Bouza JM; Ortega Lafont M; Ortiz de Lejarazu R; Bachiller Luque P; de Luis Román DA An Med Interna; 2003 May; 20(5):239-42. PubMed ID: 12831297 [TBL] [Abstract][Full Text] [Related]
25. Antiretroviral efficacy and virological profile of a zidovudine/lamivudine/tenofovir disoproxil fumarate combination therapy in antiretroviral-naive patients. Masquelier B; Neau D; Boucher S; Lavignolle-Aurillac V; Schrive MH; Recordon-Pinson P; Ragnaud JM; Fleury H Antivir Ther; 2006; 11(6):827-30. PubMed ID: 17310827 [TBL] [Abstract][Full Text] [Related]
26. Twice-daily amprenavir 1200 mg versus amprenavir 600 mg/ritonavir 100 mg, in combination with at least 2 other antiretroviral drugs, in HIV-1-infected patients. Nadler JP; Gathe JC; Pollard RB; Richmond GJ; Liao Q; Griffith S; Lancaster CT; Hernandez JE; Pappa KA; BMC Infect Dis; 2003 Jun; 3():10. PubMed ID: 12795812 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of ritonavir/indinavir 100/400 mg twice daily in combination with two nucleoside analogues in antiretroviral treatment-naive HIV-infected individuals. Duvivier C; Myrto A; Marcelin AG; Ghosn J; Ait-Mohand H; Schneider L; Agher R; Bricaire F; Costagliola D; Calvez V; Peytavin G; Katlama C Antivir Ther; 2003 Dec; 8(6):603-9. PubMed ID: 14760894 [TBL] [Abstract][Full Text] [Related]
28. A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection. Cardiello PG; Hassink E; Ananworanich J; Srasuebkul P; Samor T; Mahanontharit A; Ruxrungtham K; Hirschel B; Lange J; Phanuphak P; Cooper DA Clin Infect Dis; 2005 Feb; 40(4):594-600. PubMed ID: 15712083 [TBL] [Abstract][Full Text] [Related]
29. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients. Idoko JA; Akinsete L; Abalaka AD; Keshinro LB; Dutse L; Onyenekwe B; Lhekwaba A; Njoku OS; Kehinde MO; Wambebe CO West Afr J Med; 2002; 21(2):83-6. PubMed ID: 12403023 [TBL] [Abstract][Full Text] [Related]
30. Once-daily dosing of saquinavir soft-gel capsules and ritonavir combination in HIV-1-infected patients (IMEA015 study). Lamotte C; Landman R; Peytavin G; Mentre F; Gerbe J; Brun-Vezinet F; Boue F; Spiridon G; Valantin MA; Michelet C; Farinotti R; Yeni P Antivir Ther; 2004 Apr; 9(2):247-56. PubMed ID: 15134187 [TBL] [Abstract][Full Text] [Related]
32. Drug combination shows benefits for AIDS patients with history of taking AZT. AIDS Patient Care STDS; 1996 Jun; 10(3):185-6. PubMed ID: 11361628 [No Abstract] [Full Text] [Related]
33. Potent new AIDS drugs underscore promise of combination therapy. AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225 [TBL] [Abstract][Full Text] [Related]
34. A combination of nucleoside analogues and a protease inhibitor reduces HIV-1 RNA levels in semen: implications for sexual transmission of HIV infection. Liuzzi G; Chirianni A; Bagnarelli P; Clementi M; Piazza M Antivir Ther; 1999; 4(2):95-9. PubMed ID: 10682154 [TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of saquinavir soft-gelatin capsules + zidovudine + optional lamivudine in pregnancy and prevention of vertical HIV transmission. Vithayasai V; Moyle GJ; Supajatura V; Wattanatchariya N; Kanshana S; Sirichthaporn P; Dabtham K; Somburanasin P; Chantawuttinan T; Hill AM; Hawkins D J Acquir Immune Defic Syndr; 2002 Aug; 30(4):410-2. PubMed ID: 12138347 [TBL] [Abstract][Full Text] [Related]
36. New ways to take old drugs. Miller G STEP Perspect; 1998; 98(1):2-3. PubMed ID: 11365212 [TBL] [Abstract][Full Text] [Related]
37. Drug companies seek trial participants. AIDS Alert; 1995 Jun; 10(6):82. PubMed ID: 11362432 [TBL] [Abstract][Full Text] [Related]